A Single-Blinded, Randomized, Controlled, Phase 2 Pilot Study to Evaluate the Safety and Efficacy of Denosumab Compared to Zoledronic Acid for the Treatment of Osteoporosis in Children
Phase of Trial: Phase II
Latest Information Update: 30 Nov 2017
At a glance
- Drugs Denosumab (Primary) ; Zoledronic acid
- Indications Osteoporosis
- Focus Therapeutic Use
- 22 Nov 2017 Planned End Date changed from 1 Mar 2018 to 1 Mar 2019.
- 22 Nov 2017 Planned primary completion date changed from 1 Mar 2018 to 1 Mar 2019.
- 24 Nov 2016 Status changed from not yet recruiting to recruiting.